Global Dermal Fillers Market By Type (HA Dermal Fillers (Monophasic HA Fillers, Biphasic HA Fillers) Polymethylmethacrylate (PMMA) Filler, Collagen, Poly-L- Lactic Acid (PLLA), Calcium Hydroxylapatite (CaHA, Polytetrafluoroethylene, Autologous Fat)) By Application (Wrinkles, Lip Enhancement, Facial Contouring, Glabellar Furrows, Peri-Orbital, Others (Scars, Crow’s Feet, Etc.) By Distribution Channel (Online, Offline (Retail Stores and Drug Stores, Clinical Pharmacies, Others)) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2023 – 2031
Industry Trends
Global dermal fillers market was valued at USD 5.56 Billion in 2022, with an estimated CAGR of 8.1% from 2023 - 2031.
In recent years, dermal fillers have advanced significantly. There are more alternatives than ever before for women who wish to slow down the ageing process, and new ones are now being researched that will allow the effects of these therapies to last up to 15 months. Dermal fillers now available on the market have a six-month shelf life before the procedure needs to be redone. Dermatologists are finding success with novel techniques for injecting these face fillers for their patients in addition to the new formulations being tried. Historically, the market for cosmetic injectables has increased by more than 10% annually. Global prevalence has grown, particularly in emerging nations, due to increased availability of treatments (mainly through chains of aesthetics clinics, med spas, and beauty bars) and rising consumer spending power. Aesthetics are more widely known and accepted as a result of changing consumer attitude about wellness, attractiveness, and healthy ageing, which has led to demand from new patient categories such as males and millennials, which is propelling the global dermal fillers market demand.
Global Dermal Fillers Market Revenue & Forecast, (US$ Million), 2015 – 2031
The dermal fillers market is expected to develop throughout the forecasted years as more people have access to cosmetic operations. Consolidation and growth are two pressure tugging channels in opposite directions. On the one hand, chains of cosmetic clinics are merging to improve their growth prospects. On the other hand, a lot of new medical specialists are entering the market to offer services in aesthetics, such as auxiliary services in dental procedures or nurse-administered treatments in sizable practices with an aesthetically-focused idea. Patients now have more alternatives for where to get treatment because of the proliferation of aesthetics service providers.
Based on the type, hyaluronic fillers had the highest share in the global dermal fillers market in the year 2022. During the past few years, hyaluronic acid fillers have gained popularity as soft tissue filler augmentation agents. With a variety of novel products now accessible to patients, they have contributed to the revolutionizing of the filler industry. In addition to looking natural after injection, one of the primary advantages of HA fillers is that they may be removed using a specific solution in the event of a negative reaction or if the patient doesn't like the way they look. In order to increase patient comfort during treatment, lidocaine, a numbing agent, is typically premixed with HA fillers. On the other hand, there are a number of widely available dermal fillers made of calcium hydroxylapatite, poly-L-lactic acid, polymethyl methacrylate, and autologous fat. Individuals who choose to have dermal filler treatments are well aware of the benefits and drawbacks as well as the differences in density, longevity, and texture, which means a certain substance may be more suited to a particular area of the face or the intended outcome in some cases. Hence, in order to select the proper type of dermal filler, people are on the lookout for medical specialists.
North America had the highest share in the dermal fillers market in 2022. In United States and Canada the primary force behind the cosmetic surgery industry is Hollywood. This is due to Hollywood's reputation for establishing beauty standards both on and off the screen. The fact that many famous people have turned to cosmetic surgery to improve their appearance has majorly impacted on the amount of people who would follow their example. The dermal fillers market expansion is anticipated to be positively impacted by the rise of medical spas, rejuvenation facilities, and primary care clinics that offer aesthetic medicine. At medical spas across the United States, facial fillers make up the largest revenue-generating segment. Prominent manufacturers in the market, including Allergan, is putting more money into the creation of biodegradable fillers. The market for temporary biodegradable dermal fillers has expanded over the years as a consequence of rising demand, which has been fueled by an emphasis on aesthetic value and shorter periods.
Competitive Landscape
The report provides both, qualitative and quantitative research of global dermal fillers market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global dermal fillers market are
- Allergan Plc (AbbVie)
- BioPlus Co., Ltd
- Bohus BioTech AB
- Fidia Farmaceutici S.p.A
- Galderma
- LG Lifescienecs
- Luminera Derm Ltd
- Matex Lab SA (Neauvia)
- Merz Pharma
- Prollenium Medical Technologies.
- SciVision Biotech Inc.
- Sinclair Pharma
- Suneva Medical, Inc
- Teoxane
- Zimmer Aesthetics
- Other Industry Participants
Global Dermal Fillers Market:
By Type
- HA Dermal Fillers
- Monophasic HA Fillers
- Biphasic HA Fillers
- Polymethylmethacrylate (PMMA) Filler
- Collagen
- Poly-L- Lactic Acid (PLLA)
- Calcium Hydroxylapatite (CaHA)
- Polytetrafluoroethylene
- Autologous Fat
By Application
- Wrinkles
- Lip Enhancement
- Facial Contouring
- Glabellar Furrows
- Peri-Orbital
- Others (Scars, Crow’s Feet, Etc.)
By Distribution Channel
- Online
- Offline
- Retail stores and Drug stores
- Clinical pharmacies
- Others
By Region
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
- Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2021
1.2.2. Base Year: 2022
1.2.3. Forecast Years: 2023 – 2031
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Dermal Fillers Market
6.
Market
Synopsis: Dermal Fillers Market
7.
Dermal
Fillers Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Dermal Fillers Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Dermal Fillers Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Dermal Fillers Market
8.
Global
Dermal Fillers Market Analysis and Forecasts, 2023 - 2031
8.1. Overview
8.1.1. Global Dermal Fillers Market Revenue (US$ Mn)
8.2. Global Dermal Fillers Market Revenue (US$ Mn)
and Forecasts, By Type
8.2.1. Hyaluronic Dermal Fillers (Definition, Market
Estimation and Penetration, 2015 - 2022, Market Estimation (2015 - 2022),
Market Forecast (2023 - 2031), Compound Annual Growth Rate (CAGR), Regional
Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin
America) and Information on Monophasic HA Fillers, Biphasic HA Fillers)
8.2.1.1.
Monophasic
HA Fillers
8.2.1.2.
Biphasic
HA Fillers
8.2.2. Polymethylmethacrylate (PMMA)
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2015 - 2022
8.2.2.3.
Market
Forecast, 2023 - 2031
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1. Market Estimation, 2015 - 2022
8.2.2.5.1.2. Market Forecast, 2023 - 2031
8.2.2.5.2.
Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2022
8.2.2.5.2.2. Market Forecast, 2023 - 2031
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2022
8.2.2.5.3.2. Market Forecast, 2023 - 2031
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2022
8.2.2.5.4.2. Market Forecast, 2023 - 2031
8.2.2.5.5.
Latin
America
8.2.2.5.5.1. Market Estimation, 2015 - 2022
8.2.2.5.5.2. Market Forecast, 2023 - 2031
8.2.3. Collagen
8.2.3.1.
Definition
8.2.3.2.
Market
Estimation and Penetration, 2015 - 2022
8.2.3.3.
Market
Forecast, 2023 - 2031
8.2.3.4.
Compound
Annual Growth Rate (CAGR)
8.2.3.5.
Regional
Bifurcation
8.2.3.5.1.
North
America
8.2.3.5.1.1. Market Estimation, 2015 - 2022
8.2.3.5.1.2. Market Forecast, 2023 - 2031
8.2.3.5.2.
Europe
8.2.3.5.2.1. Market Estimation, 2015 - 2022
8.2.3.5.2.2. Market Forecast, 2023 - 2031
8.2.3.5.3.
Asia
Pacific
8.2.3.5.3.1. Market Estimation, 2015 - 2022
8.2.3.5.3.2. Market Forecast, 2023 - 2031
8.2.3.5.4.
Middle
East and Africa
8.2.3.5.4.1. Market Estimation, 2015 - 2022
8.2.3.5.4.2. Market Forecast, 2023 - 2031
8.2.3.5.5.
Latin
America
8.2.3.5.5.1. Market Estimation, 2015 - 2022
8.2.3.5.5.2. Market Forecast, 2023 - 2031
8.2.4. Poly-L- Lactic Acid (PLLA)
8.2.4.1.
Definition
8.2.4.2.
Market
Estimation and Penetration, 2015 - 2022
8.2.4.3.
Market
Forecast, 2023 - 2031
8.2.4.4.
Compound
Annual Growth Rate (CAGR)
8.2.4.5.
Regional
Bifurcation
8.2.4.5.1.
North
America
8.2.4.5.1.1. Market Estimation, 2015 - 2022
8.2.4.5.1.2. Market Forecast, 2023 - 2031
8.2.4.5.2.
Europe
8.2.4.5.2.1. Market Estimation, 2015 - 2022
8.2.4.5.2.2. Market Forecast, 2023 - 2031
8.2.4.5.3.
Asia
Pacific
8.2.4.5.3.1. Market Estimation, 2015 - 2022
8.2.4.5.3.2. Market Forecast, 2023 - 2031
8.2.4.5.4.
Middle
East and Africa
8.2.4.5.4.1. Market Estimation, 2015 - 2022
8.2.4.5.4.2. Market Forecast, 2023 - 2031
8.2.4.5.5.
Latin
America
8.2.4.5.5.1. Market Estimation, 2015 - 2022
8.2.4.5.5.2. Market Forecast, 2023 - 2031
8.2.5. Calcium Hydroxylapatite (CaHA)
8.2.5.1.
Definition
8.2.5.2.
Market
Estimation and Penetration, 2015 - 2022
8.2.5.3.
Market
Forecast, 2023 - 2031
8.2.5.4.
Compound
Annual Growth Rate (CAGR)
8.2.5.5.
Regional
Bifurcation
8.2.5.5.1.
North
America
8.2.5.5.1.1. Market Estimation, 2015 - 2022
8.2.5.5.1.2. Market Forecast, 2023 - 2031
8.2.5.5.2.
Europe
8.2.5.5.2.1. Market Estimation, 2015 - 2022
8.2.5.5.2.2. Market Forecast, 2023 - 2031
8.2.5.5.3.
Asia
Pacific
8.2.5.5.3.1. Market Estimation, 2015 - 2022
8.2.5.5.3.2. Market Forecast, 2023 - 2031
8.2.5.5.4.
Middle
East and Africa
8.2.5.5.4.1. Market Estimation, 2015 - 2022
8.2.5.5.4.2. Market Forecast, 2023 - 2031
8.2.5.5.5.
Latin
America
8.2.5.5.5.1. Market Estimation, 2015 - 2022
8.2.5.5.5.2. Market Forecast, 2023 - 2031
8.2.6. Polytetrafluoroethylene
8.2.6.1.
Definition
8.2.6.2.
Market
Estimation and Penetration, 2015 - 2022
8.2.6.3.
Market
Forecast, 2023 - 2031
8.2.6.4.
Compound
Annual Growth Rate (CAGR)
8.2.6.5.
Regional
Bifurcation
8.2.6.5.1.
North
America
8.2.6.5.1.1. Market Estimation, 2015 - 2022
8.2.6.5.1.2. Market Forecast, 2023 - 2031
8.2.6.5.2.
Europe
8.2.6.5.2.1. Market Estimation, 2015 - 2022
8.2.6.5.2.2. Market Forecast, 2023 - 2031
8.2.6.5.3.
Asia
Pacific
8.2.6.5.3.1. Market Estimation, 2015 - 2022
8.2.6.5.3.2. Market Forecast, 2023 - 2031
8.2.6.5.4.
Middle
East and Africa
8.2.6.5.4.1. Market Estimation, 2015 - 2022
8.2.6.5.4.2. Market Forecast, 2023 - 2031
8.2.6.5.5.
Latin
America
8.2.6.5.5.1. Market Estimation, 2015 - 2022
8.2.6.5.5.2. Market Forecast, 2023 - 2031
8.2.7. Autologous Fat
8.2.7.1.
Definition
8.2.7.2.
Market
Estimation and Penetration, 2015 - 2022
8.2.7.3.
Market
Forecast, 2023 - 2031
8.2.7.4.
Compound
Annual Growth Rate (CAGR)
8.2.7.5.
Regional
Bifurcation
8.2.7.5.1.
North
America
8.2.7.5.1.1. Market Estimation, 2015 - 2022
8.2.7.5.1.2. Market Forecast, 2023 - 2031
8.2.7.5.2.
Europe
8.2.7.5.2.1. Market Estimation, 2015 - 2022
8.2.7.5.2.2. Market Forecast, 2023 - 2031
8.2.7.5.3.
Asia
Pacific
8.2.7.5.3.1. Market Estimation, 2015 - 2022
8.2.7.5.3.2. Market Forecast, 2023 - 2031
8.2.7.5.4.
Middle
East and Africa
8.2.7.5.4.1. Market Estimation, 2015 - 2022
8.2.7.5.4.2. Market Forecast, 2023 - 2031
8.2.7.5.5.
Latin
America
8.2.7.5.5.1. Market Estimation, 2015 - 2022
8.2.7.5.5.2. Market Forecast, 2023 - 2031
8.3. Key Segment for Channeling Investments
8.3.1. By Type
9.
Global
Dermal Fillers Market Analysis and Forecasts, 2023 - 2031
9.1. Overview
9.2. Global Dermal Fillers Market Revenue (US$ Mn)
and Forecasts, By Application
9.2.1. Wrinkles
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2015 - 2022
9.2.1.3.
Market
Forecast, 2023 - 2031
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1. Market Estimation, 2015 - 2022
9.2.1.5.1.2. Market Forecast, 2023 - 2031
9.2.1.5.2.
Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2022
9.2.1.5.2.2. Market Forecast, 2023 - 2031
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2022
9.2.1.5.3.2. Market Forecast, 2023 - 2031
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2022
9.2.1.5.4.2. Market Forecast, 2023 - 2031
9.2.1.5.5.
Latin
America
9.2.1.5.5.1. Market Estimation, 2015 - 2022
9.2.1.5.5.2. Market Forecast, 2023 - 2031
9.2.2. Lip Enhancement
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2022
9.2.2.3.
Market
Forecast, 2023 - 2031
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2015 - 2022
9.2.2.5.1.2. Market Forecast, 2023 - 2031
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2022
9.2.2.5.2.2. Market Forecast, 2023 - 2031
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2022
9.2.2.5.3.2. Market Forecast, 2023 - 2031
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2022
9.2.2.5.4.2. Market Forecast, 2023 - 2031
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2015 - 2022
9.2.2.5.5.2. Market Forecast, 2023 - 2031
9.2.3. Facial Contouring
9.2.3.1.
Definition
9.2.3.2.
Market
Estimation and Penetration, 2015 - 2022
9.2.3.3.
Market
Forecast, 2023 - 2031
9.2.3.4.
Compound
Annual Growth Rate (CAGR)
9.2.3.5.
Regional
Bifurcation
9.2.3.5.1.
North
America
9.2.3.5.1.1. Market Estimation, 2015 - 2022
9.2.3.5.1.2. Market Forecast, 2023 - 2031
9.2.3.5.2.
Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2022
9.2.3.5.2.2. Market Forecast, 2023 - 2031
9.2.3.5.3.
Asia
Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2022
9.2.3.5.3.2. Market Forecast, 2023 - 2031
9.2.3.5.4.
Middle
East and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2022
9.2.3.5.4.2. Market Forecast, 2023 - 2031
9.2.3.5.5.
Latin
America
9.2.3.5.5.1. Market Estimation, 2015 - 2022
9.2.3.5.5.2. Market Forecast, 2023 - 2031
9.2.4. Glabellar Furrows
9.2.4.1.
Definition
9.2.4.2.
Market
Estimation and Penetration, 2015 - 2022
9.2.4.3.
Market
Forecast, 2023 - 2031
9.2.4.4.
Compound
Annual Growth Rate (CAGR)
9.2.4.5.
Regional
Bifurcation
9.2.4.5.1.
North
America
9.2.4.5.1.1. Market Estimation, 2015 - 2022
9.2.4.5.1.2. Market Forecast, 2023 - 2031
9.2.4.5.2.
Europe
9.2.4.5.2.1. Market Estimation, 2015 - 2022
9.2.4.5.2.2. Market Forecast, 2023 - 2031
9.2.4.5.3.
Asia
Pacific
9.2.4.5.3.1. Market Estimation, 2015 - 2022
9.2.4.5.3.2. Market Forecast, 2023 - 2031
9.2.4.5.4.
Middle
East and Africa
9.2.4.5.4.1. Market Estimation, 2015 - 2022
9.2.4.5.4.2. Market Forecast, 2023 - 2031
9.2.4.5.5.
Latin
America
9.2.4.5.5.1. Market Estimation, 2015 - 2022
9.2.4.5.5.2. Market Forecast, 2023 - 2031
9.2.5. Peri-Orbital
9.2.5.1.
Definition
9.2.5.2.
Market
Estimation and Penetration, 2015 - 2022
9.2.5.3.
Market
Forecast, 2023 - 2031
9.2.5.4.
Compound
Annual Growth Rate (CAGR)
9.2.5.5.
Regional
Bifurcation
9.2.5.5.1.
North
America
9.2.5.5.1.1. Market Estimation, 2015 - 2022
9.2.5.5.1.2. Market Forecast, 2023 - 2031
9.2.5.5.2.
Europe
9.2.5.5.2.1. Market Estimation, 2015 - 2022
9.2.5.5.2.2. Market Forecast, 2023 - 2031
9.2.5.5.3.
Asia
Pacific
9.2.5.5.3.1. Market Estimation, 2015 - 2022
9.2.5.5.3.2. Market Forecast, 2023 - 2031
9.2.5.5.4.
Middle
East and Africa
9.2.5.5.4.1. Market Estimation, 2015 - 2022
9.2.5.5.4.2. Market Forecast, 2023 - 2031
9.2.5.5.5.
Latin
America
9.2.5.5.5.1. Market Estimation, 2015 - 2022
9.2.5.5.5.2. Market Forecast, 2023 - 2031
9.2.6. Others
9.2.6.1.
Definition
9.2.6.2.
Market
Estimation and Penetration, 2015 - 2022
9.2.6.3.
Market
Forecast, 2023 - 2031
9.2.6.4.
Compound
Annual Growth Rate (CAGR)
9.2.6.5.
Regional
Bifurcation
9.2.6.5.1.
North
America
9.2.6.5.1.1. Market Estimation, 2015 - 2022
9.2.6.5.1.2. Market Forecast, 2023 - 2031
9.2.6.5.2.
Europe
9.2.6.5.2.1. Market Estimation, 2015 - 2022
9.2.6.5.2.2. Market Forecast, 2023 - 2031
9.2.6.5.3.
Asia
Pacific
9.2.6.5.3.1. Market Estimation, 2015 - 2022
9.2.6.5.3.2. Market Forecast, 2023 - 2031
9.2.6.5.4.
Middle
East and Africa
9.2.6.5.4.1. Market Estimation, 2015 - 2022
9.2.6.5.4.2. Market Forecast, 2023 - 2031
9.2.6.5.5.
Latin
America
9.2.6.5.5.1. Market Estimation, 2015 - 2022
9.2.6.5.5.2. Market Forecast, 2023 - 2031
9.3. Key Segment for Channeling Investments
9.3.1. By Application
10. Global Dermal Fillers Market Analysis and
Forecasts, 2023 - 2031
10.1. Overview
10.2. Global Dermal Fillers Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
10.2.1. Online
10.2.1.1.
Definition
10.2.1.2.
Market
Estimation and Penetration, 2015 - 2022
10.2.1.3.
Market
Forecast, 2023 - 2031
10.2.1.4.
Compound
Annual Growth Rate (CAGR)
10.2.1.5.
Regional
Bifurcation
10.2.1.5.1.
North
America
10.2.1.5.1.1. Market Estimation, 2015 - 2022
10.2.1.5.1.2. Market Forecast, 2023 - 2031
10.2.1.5.2.
Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2022
10.2.1.5.2.2. Market Forecast, 2023 - 2031
10.2.1.5.3.
Asia
Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2022
10.2.1.5.3.2. Market Forecast, 2023 - 2031
10.2.1.5.4.
Middle
East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2022
10.2.1.5.4.2. Market Forecast, 2023 - 2031
10.2.1.5.5.
Latin
America
10.2.1.5.5.1. Market Estimation, 2015 - 2022
10.2.1.5.5.2. Market Forecast, 2023 - 2031
10.2.2. Offline
(Definition, Market Estimation and Penetration, 2015 - 2022, Market
Estimation (2015 - 2022), Market Forecast (2023 - 2031), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on Retail stores and Drug
stores, Clinical pharmacies, Others )
10.2.2.1.
Retail
stores and Drug stores
10.2.2.2.
Clinical
pharmacies
10.2.2.3.
Others
10.3. Key Segment for Channeling Investments
10.3.1. By Distribution Channel
11. North America Dermal Fillers Market Analysis
and Forecasts, 2023 - 2031
11.1. Overview
11.1.1. North America Dermal Fillers Market Revenue
(US$ Mn)
11.2. North America Dermal Fillers Market Revenue
(US$ Mn) and Forecasts, By Type
11.2.1. Hyaluronic Dermal Fillers
11.2.1.1.
Monophasic
HA Fillers
11.2.1.2.
Biphasic
HA Fillers
11.2.2. Polymethylmethacrylate (PMMA)
11.2.3. Collagen
11.2.4. Poly-L- Lactic Acid (PLLA)
11.2.5. Calcium Hydroxylapatite (CaHA)
11.2.6. Polytetrafluoroethylene
11.2.7. Autologous Fat
11.3. North America Dermal Fillers Market Revenue
(US$ Mn) and Forecasts, By Application
11.3.1. Wrinkles
11.3.2. Lip Enhancement
11.3.3. Facial Contouring
11.3.4. Glabellar Furrows
11.3.5. Peri-Orbital
11.3.6. Others
11.4. North America Dermal Fillers Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
11.4.1. Online
11.4.2. Offline
11.4.2.1.
Retail
stores and Drug stores
11.4.2.2.
Clinical
pharmacies
11.4.2.3.
Others
11.5. North America Dermal Fillers Market Revenue
(US$ Mn) and Forecasts, By Country
11.5.1. U.S
11.5.1.1.
U.S
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
11.5.1.1.1.
Hyaluronic
Dermal Fillers
11.5.1.1.1.1. Monophasic HA Fillers
11.5.1.1.1.2. Biphasic HA Fillers
11.5.1.1.2.
Polymethylmethacrylate
(PMMA)
11.5.1.1.3.
Collagen
11.5.1.1.4.
Poly-L-
Lactic Acid (PLLA)
11.5.1.1.5.
Calcium Hydroxylapatite
(CaHA)
11.5.1.1.6.
Polytetrafluoroethylene
11.5.1.1.7.
Autologous
Fat
11.5.1.2.
U.S
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
11.5.1.2.1.
Wrinkles
11.5.1.2.2.
Lip
Enhancement
11.5.1.2.3.
Facial
Contouring
11.5.1.2.4.
Glabellar
Furrows
11.5.1.2.5.
Peri-Orbital
11.5.1.2.6.
Others
11.5.1.3.
U.S
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
11.5.1.3.1.
Online
11.5.1.3.2.
Offline
11.5.1.3.2.1. Retail stores and Drug stores
11.5.1.3.2.2. Clinical pharmacies
11.5.1.3.2.3. Others
11.5.2. Canada
11.5.2.1.
Canada
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
11.5.2.1.1.
Hyaluronic
Dermal Fillers
11.5.2.1.1.1. Monophasic HA Fillers
11.5.2.1.1.2. Biphasic HA Fillers
11.5.2.1.2.
Polymethylmethacrylate
(PMMA)
11.5.2.1.3.
Collagen
11.5.2.1.4.
Poly-L-
Lactic Acid (PLLA)
11.5.2.1.5.
Calcium
Hydroxylapatite (CaHA)
11.5.2.1.6.
Polytetrafluoroethylene
11.5.2.1.7.
Autologous
Fat
11.5.2.2.
Canada
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
11.5.2.2.1.
Wrinkles
11.5.2.2.2.
Lip
Enhancement
11.5.2.2.3.
Facial Contouring
11.5.2.2.4.
Glabellar
Furrows
11.5.2.2.5.
Peri-Orbital
11.5.2.2.6.
Others
11.5.2.3.
Canada
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
11.5.2.3.1.
Online
11.5.2.3.2.
Offline
11.5.2.3.2.1. Retail stores and Drug stores
11.5.2.3.2.2. Clinical pharmacies
11.5.2.3.2.3. Others
11.5.3. Mexico
11.5.3.1.
Mexico
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
11.5.3.1.1.
Hyaluronic
Dermal Fillers
11.5.3.1.1.1. Monophasic HA Fillers
11.5.3.1.1.2. Biphasic HA Fillers
11.5.3.1.2.
Polymethylmethacrylate
(PMMA)
11.5.3.1.3.
Collagen
11.5.3.1.4.
Poly-L-
Lactic Acid (PLLA)
11.5.3.1.5.
Calcium
Hydroxylapatite (CaHA)
11.5.3.1.6.
Polytetrafluoroethylene
11.5.3.1.7.
Autologous
Fat
11.5.3.2.
Mexico
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
11.5.3.2.1.
Wrinkles
11.5.3.2.2.
Lip
Enhancement
11.5.3.2.3.
Facial
Contouring
11.5.3.2.4.
Glabellar
Furrows
11.5.3.2.5.
Peri-Orbital
11.5.3.2.6.
Others
11.5.3.3.
Mexico
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
11.5.3.3.1.
Online
11.5.3.3.2.
Offline
11.5.3.3.2.1. Retail stores and Drug stores
11.5.3.3.2.2. Clinical pharmacies
11.5.3.3.2.3. Others
11.5.4. Rest of North America
11.5.4.1.
Rest of
North America Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
11.5.4.1.1.
Hyaluronic
Dermal Fillers
11.5.4.1.1.1. Monophasic HA Fillers
11.5.4.1.1.2. Biphasic HA Fillers
11.5.4.1.2.
Polymethylmethacrylate
(PMMA)
11.5.4.1.3.
Collagen
11.5.4.1.4.
Poly-L-
Lactic Acid (PLLA)
11.5.4.1.5.
Calcium
Hydroxylapatite (CaHA)
11.5.4.1.6.
Polytetrafluoroethylene
11.5.4.1.7.
Autologous
Fat
11.5.4.2.
Rest of
North America Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By
Application
11.5.4.2.1.
Wrinkles
11.5.4.2.2.
Lip
Enhancement
11.5.4.2.3.
Facial
Contouring
11.5.4.2.4.
Glabellar
Furrows
11.5.4.2.5.
Peri-Orbital
11.5.4.2.6.
Others
11.5.4.3.
Rest of
North America Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
11.5.4.3.1.
Online
11.5.4.3.2.
Offline
11.5.4.3.2.1. Retail stores and Drug stores
11.5.4.3.2.2. Clinical pharmacies
11.5.4.3.2.3. Others
11.6. Key Segment for Channeling Investments
11.6.1. By Country
11.6.2. By Type
11.6.3. By Application
11.6.4. By Distribution Channel
12. Europe Dermal Fillers Market Analysis and
Forecasts, 2023 - 2031
12.1. Overview
12.1.1. Europe Dermal Fillers Market Revenue (US$ Mn)
12.2. Europe Dermal Fillers Market Revenue (US$ Mn)
and Forecasts, By Type
12.2.1. Hyaluronic Dermal Fillers
12.2.1.1.
Monophasic
HA Fillers
12.2.1.2.
Biphasic
HA Fillers
12.2.2. Polymethylmethacrylate (PMMA)
12.2.3. Collagen
12.2.4. Poly-L- Lactic Acid (PLLA)
12.2.5. Calcium Hydroxylapatite (CaHA)
12.2.6. Polytetrafluoroethylene
12.2.7. Autologous Fat
12.3. Europe Dermal Fillers Market Revenue (US$ Mn)
and Forecasts, By Application
12.3.1. Wrinkles
12.3.2. Lip Enhancement
12.3.3. Facial Contouring
12.3.4. Glabellar Furrows
12.3.5. Peri-Orbital
12.3.6. Others
12.4. Europe Dermal Fillers Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
12.4.1. Online
12.4.2. Offline
12.4.2.1.
Retail
stores and Drug stores
12.4.2.2.
Clinical
pharmacies
12.4.2.3.
Others
12.5. Europe Dermal Fillers Market Revenue (US$ Mn)
and Forecasts, By Country
12.5.1. France
12.5.1.1.
France
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
12.5.1.1.1.
Hyaluronic
Dermal Fillers
12.5.1.1.1.1. Monophasic HA Fillers
12.5.1.1.1.2. Biphasic HA Fillers
12.5.1.1.2.
Polymethylmethacrylate
(PMMA)
12.5.1.1.3.
Collagen
12.5.1.1.4.
Poly-L-
Lactic Acid (PLLA)
12.5.1.1.5.
Calcium
Hydroxylapatite (CaHA)
12.5.1.1.6.
Polytetrafluoroethylene
12.5.1.1.7.
Autologous
Fat
12.5.1.2.
France
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
12.5.1.2.1.
Wrinkles
12.5.1.2.2.
Lip
Enhancement
12.5.1.2.3.
Facial
Contouring
12.5.1.2.4.
Glabellar
Furrows
12.5.1.2.5.
Peri-Orbital
12.5.1.2.6.
Others
12.5.1.3.
France
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.5.1.3.1.
Online
12.5.1.3.2.
Offline
12.5.1.3.2.1. Retail stores and Drug stores
12.5.1.3.2.2. Clinical pharmacies
12.5.1.3.2.3. Others
12.5.2. The UK
12.5.2.1.
The UK
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
12.5.2.1.1.
Hyaluronic
Dermal Fillers
12.5.2.1.1.1. Monophasic HA Fillers
12.5.2.1.1.2. Biphasic HA Fillers
12.5.2.1.2.
Polymethylmethacrylate
(PMMA)
12.5.2.1.3.
Collagen
12.5.2.1.4.
Poly-L-
Lactic Acid (PLLA)
12.5.2.1.5.
Calcium
Hydroxylapatite (CaHA)
12.5.2.1.6.
Polytetrafluoroethylene
12.5.2.1.7.
Autologous
Fat
12.5.2.2.
The UK
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
12.5.2.2.1.
Wrinkles
12.5.2.2.2.
Lip
Enhancement
12.5.2.2.3.
Facial
Contouring
12.5.2.2.4.
Glabellar
Furrows
12.5.2.2.5.
Peri-Orbital
12.5.2.2.6.
Others
12.5.2.3.
The UK
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.5.2.3.1.
Online
12.5.2.3.2.
Offline
12.5.2.3.2.1. Retail stores and Drug stores
12.5.2.3.2.2. Clinical pharmacies
12.5.2.3.2.3. Others
12.5.3. Spain
12.5.3.1.
Spain
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
12.5.3.1.1.
Hyaluronic
Dermal Fillers
12.5.3.1.1.1. Monophasic HA Fillers
12.5.3.1.1.2. Biphasic HA Fillers
12.5.3.1.2.
Polymethylmethacrylate
(PMMA)
12.5.3.1.3.
Collagen
12.5.3.1.4.
Poly-L-
Lactic Acid (PLLA)
12.5.3.1.5.
Calcium
Hydroxylapatite (CaHA)
12.5.3.1.6.
Polytetrafluoroethylene
12.5.3.1.7.
Autologous
Fat
12.5.3.2.
Spain
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
12.5.3.2.1.
Wrinkles
12.5.3.2.2.
Lip
Enhancement
12.5.3.2.3.
Facial
Contouring
12.5.3.2.4.
Glabellar
Furrows
12.5.3.2.5.
Peri-Orbital
12.5.3.2.6.
Others
12.5.3.3.
Spain
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.5.3.3.1.
Online
12.5.3.3.2.
Offline
12.5.3.3.2.1. Retail stores and Drug stores
12.5.3.3.2.2. Clinical pharmacies
12.5.3.3.2.3. Others
12.5.4. Germany
12.5.4.1.
Germany
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
12.5.4.1.1.
Hyaluronic
Dermal Fillers
12.5.4.1.1.1. Monophasic HA Fillers
12.5.4.1.1.2. Biphasic HA Fillers
12.5.4.1.2.
Polymethylmethacrylate
(PMMA)
12.5.4.1.3.
Collagen
12.5.4.1.4.
Poly-L-
Lactic Acid (PLLA)
12.5.4.1.5.
Calcium
Hydroxylapatite (CaHA)
12.5.4.1.6.
Polytetrafluoroethylene
12.5.4.1.7.
Autologous
Fat
12.5.4.2.
Germany
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
12.5.4.2.1.
Wrinkles
12.5.4.2.2.
Lip
Enhancement
12.5.4.2.3.
Facial
Contouring
12.5.4.2.4.
Glabellar
Furrows
12.5.4.2.5.
Peri-Orbital
12.5.4.2.6.
Others
12.5.4.3.
Germany
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.5.4.3.1.
Online
12.5.4.3.2.
Offline
12.5.4.3.2.1. Retail stores and Drug stores
12.5.4.3.2.2. Clinical pharmacies
12.5.4.3.2.3. Others
12.5.5. Italy
12.5.5.1.
Italy
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
12.5.5.1.1.
Hyaluronic
Dermal Fillers
12.5.5.1.1.1. Monophasic HA Fillers
12.5.5.1.1.2. Biphasic HA Fillers
12.5.5.1.2.
Polymethylmethacrylate
(PMMA)
12.5.5.1.3.
Collagen
12.5.5.1.4.
Poly-L-
Lactic Acid (PLLA)
12.5.5.1.5.
Calcium
Hydroxylapatite (CaHA)
12.5.5.1.6.
Polytetrafluoroethylene
12.5.5.1.7.
Autologous
Fat
12.5.5.2.
Italy
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
12.5.5.2.1.
Wrinkles
12.5.5.2.2.
Lip
Enhancement
12.5.5.2.3.
Facial
Contouring
12.5.5.2.4.
Glabellar
Furrows
12.5.5.2.5.
Peri-Orbital
12.5.5.2.6.
Others
12.5.5.3.
Italy
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.5.5.3.1.
Online
12.5.5.3.2.
Offline
12.5.5.3.2.1. Retail stores and Drug stores
12.5.5.3.2.2. Clinical pharmacies
12.5.5.3.2.3. Others
12.5.6. Nordic Countries
12.5.6.1.
Nordic
Countries Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
12.5.6.1.1.
Hyaluronic
Dermal Fillers
12.5.6.1.1.1. Monophasic HA Fillers
12.5.6.1.1.2. Biphasic HA Fillers
12.5.6.1.2.
Polymethylmethacrylate
(PMMA)
12.5.6.1.3.
Collagen
12.5.6.1.4.
Poly-L-
Lactic Acid (PLLA)
12.5.6.1.5.
Calcium
Hydroxylapatite (CaHA)
12.5.6.1.6.
Polytetrafluoroethylene
12.5.6.1.7.
Autologous
Fat
12.5.6.2.
Nordic
Countries Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
12.5.6.2.1.
Wrinkles
12.5.6.2.2.
Lip
Enhancement
12.5.6.2.3.
Facial
Contouring
12.5.6.2.4.
Glabellar
Furrows
12.5.6.2.5.
Peri-Orbital
12.5.6.2.6.
Others
12.5.6.3.
Nordic
Countries Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
12.5.6.3.1.
Online
12.5.6.3.2.
Offline
12.5.6.3.2.1. Retail stores and Drug stores
12.5.6.3.2.2. Clinical pharmacies
12.5.6.3.2.3. Others
12.5.6.4.
Nordic
Countries Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1.
Denmark
12.5.6.4.2.
Finland
12.5.6.4.3.
Iceland
12.5.6.4.4.
Sweden
12.5.6.4.5.
Norway
12.5.7. Benelux Union
12.5.7.1.
Benelux
Union Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
12.5.7.1.1.
Hyaluronic
Dermal Fillers
12.5.7.1.1.1. Monophasic HA Fillers
12.5.7.1.1.2. Biphasic HA Fillers
12.5.7.1.2.
Polymethylmethacrylate
(PMMA)
12.5.7.1.3.
Collagen
12.5.7.1.4.
Poly-L-
Lactic Acid (PLLA)
12.5.7.1.5.
Calcium
Hydroxylapatite (CaHA)
12.5.7.1.6.
Polytetrafluoroethylene
12.5.7.1.7.
Autologous
Fat
12.5.7.2.
Benelux
Union Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
12.5.7.2.1.
Wrinkles
12.5.7.2.2.
Lip
Enhancement
12.5.7.2.3.
Facial
Contouring
12.5.7.2.4.
Glabellar
Furrows
12.5.7.2.5.
Peri-Orbital
12.5.7.2.6.
Others
12.5.7.3.
Benelux
Union Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
12.5.7.3.1.
Online
12.5.7.3.2.
Offline
12.5.7.3.2.1. Retail stores and Drug stores
12.5.7.3.2.2. Clinical pharmacies
12.5.7.3.2.3. Others
12.5.7.4.
Benelux
Union Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1.
Belgium
12.5.7.4.2.
The
Netherlands
12.5.7.4.3.
Luxembourg
12.5.8. Rest of Europe
12.5.8.1.
Rest of
Europe Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
12.5.8.1.1.
Hyaluronic
Dermal Fillers
12.5.8.1.1.1. Monophasic HA Fillers
12.5.8.1.1.2. Biphasic HA Fillers
12.5.8.1.2.
Polymethylmethacrylate
(PMMA)
12.5.8.1.3.
Collagen
12.5.8.1.4.
Poly-L-
Lactic Acid (PLLA)
12.5.8.1.5.
Calcium
Hydroxylapatite (CaHA)
12.5.8.1.6.
Polytetrafluoroethylene
12.5.8.1.7.
Autologous
Fat
12.5.8.2.
Rest of
Europe Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
12.5.8.2.1.
Wrinkles
12.5.8.2.2.
Lip
Enhancement
12.5.8.2.3.
Facial
Contouring
12.5.8.2.4.
Glabellar
Furrows
12.5.8.2.5.
Peri-Orbital
12.5.8.2.6.
Others
12.5.8.3.
Rest of
Europe Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
12.5.8.3.1.
Online
12.5.8.3.2.
Offline
12.5.8.3.2.1. Retail stores and Drug stores
12.5.8.3.2.2. Clinical pharmacies
12.5.8.3.2.3. Others
12.6. Key Segment for Channeling Investments
12.6.1. By Country
12.6.2. By Type
12.6.3. By Application
12.6.4. By Distribution Channel
13. Asia Pacific Dermal Fillers Market Analysis
and Forecasts, 2023 - 2031
13.1. Overview
13.1.1. Asia Pacific Dermal Fillers Market Revenue
(US$ Mn)
13.2. Asia Pacific Dermal Fillers Market Revenue
(US$ Mn) and Forecasts, By Type
13.2.1. Hyaluronic Dermal Fillers
13.2.1.1.
Monophasic
HA Fillers
13.2.1.2.
Biphasic
HA Fillers
13.2.2. Polymethylmethacrylate (PMMA)
13.2.3. Collagen
13.2.4. Poly-L- Lactic Acid (PLLA)
13.2.5. Calcium Hydroxylapatite (CaHA)
13.2.6. Polytetrafluoroethylene
13.2.7. Autologous Fat
13.3. Asia Pacific Dermal Fillers Market Revenue
(US$ Mn) and Forecasts, By Application
13.3.1. Wrinkles
13.3.2. Lip Enhancement
13.3.3. Facial Contouring
13.3.4. Glabellar Furrows
13.3.5. Peri-Orbital
13.3.6. Others
13.4. Asia Pacific Dermal Fillers Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
13.4.1. Online
13.4.2. Offline
13.4.2.1.
Retail
stores and Drug stores
13.4.2.2.
Clinical
pharmacies
13.4.2.3.
Others
13.5. Asia Pacific Dermal Fillers Market Revenue
(US$ Mn) and Forecasts, By Country
13.5.1. China
13.5.1.1.
China
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
13.5.1.1.1.
Hyaluronic
Dermal Fillers
13.5.1.1.1.1. Monophasic HA Fillers
13.5.1.1.1.2. Biphasic HA Fillers
13.5.1.1.2.
Polymethylmethacrylate
(PMMA)
13.5.1.1.3.
Collagen
13.5.1.1.4.
Poly-L-
Lactic Acid (PLLA)
13.5.1.1.5.
Calcium
Hydroxylapatite (CaHA)
13.5.1.1.6.
Polytetrafluoroethylene
13.5.1.1.7.
Autologous
Fat
13.5.1.2.
China
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
13.5.1.2.1.
Wrinkles
13.5.1.2.2.
Lip
Enhancement
13.5.1.2.3.
Facial
Contouring
13.5.1.2.4.
Glabellar
Furrows
13.5.1.2.5.
Peri-Orbital
13.5.1.2.6.
Others
13.5.1.3.
China
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.5.1.3.1.
Online
13.5.1.3.2.
Offline
13.5.1.3.2.1. Retail stores and Drug stores
13.5.1.3.2.2. Clinical pharmacies
13.5.1.3.2.3. Others
13.5.2. Japan
13.5.2.1.
Japan
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
13.5.2.1.1.
Hyaluronic
Dermal Fillers
13.5.2.1.1.1. Monophasic HA Fillers
13.5.2.1.1.2. Biphasic HA Fillers
13.5.2.1.2.
Polymethylmethacrylate
(PMMA)
13.5.2.1.3.
Collagen
13.5.2.1.4.
Poly-L-
Lactic Acid (PLLA)
13.5.2.1.5.
Calcium
Hydroxylapatite (CaHA)
13.5.2.1.6.
Polytetrafluoroethylene
13.5.2.1.7.
Autologous
Fat
13.5.2.2.
Japan
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
13.5.2.2.1.
Wrinkles
13.5.2.2.2.
Lip
Enhancement
13.5.2.2.3.
Facial
Contouring
13.5.2.2.4.
Glabellar
Furrows
13.5.2.2.5.
Peri-Orbital
13.5.2.2.6.
Others
13.5.2.3.
Japan
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.5.2.3.1.
Online
13.5.2.3.2.
Offline
13.5.2.3.2.1. Retail stores and Drug stores
13.5.2.3.2.2. Clinical pharmacies
13.5.2.3.2.3. Others
13.5.3. India
13.5.3.1.
India
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
13.5.3.1.1.
Hyaluronic
Dermal Fillers
13.5.3.1.1.1. Monophasic HA Fillers
13.5.3.1.1.2. Biphasic HA Fillers
13.5.3.1.2.
Polymethylmethacrylate
(PMMA)
13.5.3.1.3.
Collagen
13.5.3.1.4.
Poly-L-
Lactic Acid (PLLA)
13.5.3.1.5.
Calcium
Hydroxylapatite (CaHA)
13.5.3.1.6.
Polytetrafluoroethylene
13.5.3.1.7.
Autologous
Fat
13.5.3.2.
India
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
13.5.3.2.1.
Wrinkles
13.5.3.2.2.
Lip
Enhancement
13.5.3.2.3.
Facial
Contouring
13.5.3.2.4.
Glabellar
Furrows
13.5.3.2.5.
Peri-Orbital
13.5.3.2.6.
Others
13.5.3.3.
India
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.5.3.3.1.
Online
13.5.3.3.2.
Offline
13.5.3.3.2.1. Retail stores and Drug stores
13.5.3.3.2.2. Clinical pharmacies
13.5.3.3.2.3. Others
13.5.4. New Zealand
13.5.4.1.
New
Zealand Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
13.5.4.1.1.
Hyaluronic
Dermal Fillers
13.5.4.1.1.1. Monophasic HA Fillers
13.5.4.1.1.2. Biphasic HA Fillers
13.5.4.1.2.
Polymethylmethacrylate
(PMMA)
13.5.4.1.3.
Collagen
13.5.4.1.4.
Poly-L-
Lactic Acid (PLLA)
13.5.4.1.5.
Calcium
Hydroxylapatite (CaHA)
13.5.4.1.6.
Polytetrafluoroethylene
13.5.4.1.7.
Autologous
Fat
13.5.4.2.
New
Zealand Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
13.5.4.2.1.
Wrinkles
13.5.4.2.2.
Lip
Enhancement
13.5.4.2.3.
Facial
Contouring
13.5.4.2.4.
Glabellar
Furrows
13.5.4.2.5.
Peri-Orbital
13.5.4.2.6.
Others
13.5.4.3.
New
Zealand Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.5.4.3.1.
Online
13.5.4.3.2.
Offline
13.5.4.3.2.1. Retail stores and Drug stores
13.5.4.3.2.2. Clinical pharmacies
13.5.4.3.2.3. Others
13.5.5. Australia
13.5.5.1.
Australia
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
13.5.5.1.1.
Hyaluronic
Dermal Fillers
13.5.5.1.1.1. Monophasic HA Fillers
13.5.5.1.1.2. Biphasic HA Fillers
13.5.5.1.2.
Polymethylmethacrylate
(PMMA)
13.5.5.1.3.
Collagen
13.5.5.1.4.
Poly-L-
Lactic Acid (PLLA)
13.5.5.1.5.
Calcium
Hydroxylapatite (CaHA)
13.5.5.1.6.
Polytetrafluoroethylene
13.5.5.1.7.
Autologous
Fat
13.5.5.2.
Australia
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
13.5.5.2.1.
Wrinkles
13.5.5.2.2.
Lip
Enhancement
13.5.5.2.3.
Facial
Contouring
13.5.5.2.4.
Glabellar
Furrows
13.5.5.2.5.
Peri-Orbital
13.5.5.2.6.
Others
13.5.5.3.
Australia
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.5.5.3.1.
Online
13.5.5.3.2.
Offline
13.5.5.3.2.1. Retail stores and Drug stores
13.5.5.3.2.2. Clinical pharmacies
13.5.5.3.2.3. Others
13.5.6. South Korea
13.5.6.1.
South
Korea Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
13.5.6.1.1.
Hyaluronic
Dermal Fillers
13.5.6.1.1.1. Monophasic HA Fillers
13.5.6.1.1.2. Biphasic HA Fillers
13.5.6.1.2.
Polymethylmethacrylate
(PMMA)
13.5.6.1.3.
Collagen
13.5.6.1.4.
Poly-L-
Lactic Acid (PLLA)
13.5.6.1.5.
Calcium
Hydroxylapatite (CaHA)
13.5.6.1.6.
Polytetrafluoroethylene
13.5.6.1.7.
Autologous
Fat
13.5.6.2.
South
Korea Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
13.5.6.2.1.
Wrinkles
13.5.6.2.2.
Lip
Enhancement
13.5.6.2.3.
Facial
Contouring
13.5.6.2.4.
Glabellar
Furrows
13.5.6.2.5.
Peri-Orbital
13.5.6.2.6.
Others
13.5.6.3.
South
Korea Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.5.6.3.1.
Online
13.5.6.3.2.
Offline
13.5.6.3.2.1. Retail stores and Drug stores
13.5.6.3.2.2. Clinical pharmacies
13.5.6.3.2.3. Others
13.5.7. Southeast Asia
13.5.7.1.
Southeast
Asia Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
13.5.7.1.1.
Hyaluronic
Dermal Fillers
13.5.7.1.1.1. Monophasic HA Fillers
13.5.7.1.1.2. Biphasic HA Fillers
13.5.7.1.2.
Polymethylmethacrylate
(PMMA)
13.5.7.1.3.
Collagen
13.5.7.1.4.
Poly-L-
Lactic Acid (PLLA)
13.5.7.1.5.
Calcium
Hydroxylapatite (CaHA)
13.5.7.1.6.
Polytetrafluoroethylene
13.5.7.1.7.
Autologous
Fat
13.5.7.2.
Southeast
Asia Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
13.5.7.2.1.
Wrinkles
13.5.7.2.2.
Lip
Enhancement
13.5.7.2.3.
Facial
Contouring
13.5.7.2.4.
Glabellar
Furrows
13.5.7.2.5.
Peri-Orbital
13.5.7.2.6.
Others
13.5.7.3.
Southeast
Asia Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.5.7.3.1.
Online
13.5.7.3.2.
Offline
13.5.7.3.2.1. Retail stores and Drug stores
13.5.7.3.2.2. Clinical pharmacies
13.5.7.3.2.3. Others
13.5.7.4.
Southeast
Asia Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1.
Indonesia
13.5.7.4.2.
Thailand
13.5.7.4.3.
Malaysia
13.5.7.4.4.
Singapore
13.5.7.4.5.
Rest of
Southeast Asia
13.5.8. Rest of Asia Pacific
13.5.8.1.
Rest of
Asia Pacific Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
13.5.8.1.1.
Hyaluronic
Dermal Fillers
13.5.8.1.1.1. Monophasic HA Fillers
13.5.8.1.1.2. Biphasic HA Fillers
13.5.8.1.2.
Polymethylmethacrylate
(PMMA)
13.5.8.1.3.
Collagen
13.5.8.1.4.
Poly-L-
Lactic Acid (PLLA)
13.5.8.1.5.
Calcium
Hydroxylapatite (CaHA)
13.5.8.1.6.
Polytetrafluoroethylene
13.5.8.1.7.
Autologous
Fat
13.5.8.2.
Rest of
Asia Pacific Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By
Application
13.5.8.2.1.
Wrinkles
13.5.8.2.2.
Lip
Enhancement
13.5.8.2.3.
Facial
Contouring
13.5.8.2.4.
Glabellar
Furrows
13.5.8.2.5.
Peri-Orbital
13.5.8.2.6.
Others
13.5.8.3.
Rest of
Asia Pacific Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
13.5.8.3.1.
Online
13.5.8.3.2.
Offline
13.5.8.3.2.1. Retail stores and Drug stores
13.5.8.3.2.2. Clinical pharmacies
13.5.8.3.2.3. Others
13.6. Key Segment for Channeling Investments
13.6.1. By Country
13.6.2. By Type
13.6.3. By Application
13.6.4. By Distribution Channel
14. Middle East and Africa Dermal Fillers Market
Analysis and Forecasts, 2023 - 2031
14.1. Overview
14.1.1. Middle East and Africa Dermal Fillers Market
Revenue (US$ Mn)
14.2. Middle East and Africa Dermal Fillers Market
Revenue (US$ Mn) and Forecasts, By Type
14.2.1. Hyaluronic Dermal Fillers
14.2.1.1.
Monophasic
HA Fillers
14.2.1.2.
Biphasic
HA Fillers
14.2.2. Polymethylmethacrylate (PMMA)
14.2.3. Collagen
14.2.4. Poly-L- Lactic Acid (PLLA)
14.2.5. Calcium Hydroxylapatite (CaHA)
14.2.6. Polytetrafluoroethylene
14.2.7. Autologous Fat
14.3. Middle East and Africa Dermal Fillers Market
Revenue (US$ Mn) and Forecasts, By Application
14.3.1. Wrinkles
14.3.2. Lip Enhancement
14.3.3. Facial Contouring
14.3.4. Glabellar Furrows
14.3.5. Peri-Orbital
14.3.6. Others
14.4. Middle East and Africa Dermal Fillers Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.4.1. Online
14.4.2. Offline
14.4.2.1.
Retail
stores and Drug stores
14.4.2.2.
Clinical
pharmacies
14.4.2.3.
Others
14.5. Middle East and Africa Dermal Fillers Market
Revenue (US$ Mn) and Forecasts, By Country
14.5.1. Saudi Arabia
14.5.1.1.
Saudi
Arabia Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
14.5.1.1.1.
Hyaluronic
Dermal Fillers
14.5.1.1.1.1. Monophasic HA Fillers
14.5.1.1.1.2. Biphasic HA Fillers
14.5.1.1.2.
Polymethylmethacrylate
(PMMA)
14.5.1.1.3.
Collagen
14.5.1.1.4.
Poly-L-
Lactic Acid (PLLA)
14.5.1.1.5.
Calcium
Hydroxylapatite (CaHA)
14.5.1.1.6.
Polytetrafluoroethylene
14.5.1.1.7.
Autologous
Fat
14.5.1.2.
Saudi
Arabia Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
14.5.1.2.1.
Wrinkles
14.5.1.2.2.
Lip Enhancement
14.5.1.2.3.
Facial
Contouring
14.5.1.2.4.
Glabellar
Furrows
14.5.1.2.5.
Peri-Orbital
14.5.1.2.6.
Others
14.5.1.3.
Saudi
Arabia Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.5.1.3.1.
Online
14.5.1.3.2.
Offline
14.5.1.3.2.1. Retail stores and Drug stores
14.5.1.3.2.2. Clinical pharmacies
14.5.1.3.2.3. Others
14.5.2. UAE
14.5.2.1.
UAE
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
14.5.2.1.1.
Hyaluronic
Dermal Fillers
14.5.2.1.1.1. Monophasic HA Fillers
14.5.2.1.1.2. Biphasic HA Fillers
14.5.2.1.2.
Polymethylmethacrylate
(PMMA)
14.5.2.1.3.
Collagen
14.5.2.1.4.
Poly-L-
Lactic Acid (PLLA)
14.5.2.1.5.
Calcium
Hydroxylapatite (CaHA)
14.5.2.1.6.
Polytetrafluoroethylene
14.5.2.1.7.
Autologous
Fat
14.5.2.2.
UAE Dermal
Fillers Market Revenue (US$ Mn) and Forecasts, By Application
14.5.2.2.1.
Wrinkles
14.5.2.2.2.
Lip
Enhancement
14.5.2.2.3.
Facial
Contouring
14.5.2.2.4.
Glabellar
Furrows
14.5.2.2.5.
Peri-Orbital
14.5.2.2.6.
Others
14.5.2.3.
UAE
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.5.2.3.1.
Online
14.5.2.3.2.
Offline
14.5.2.3.2.1. Retail stores and Drug stores
14.5.2.3.2.2. Clinical pharmacies
14.5.2.3.2.3. Others
14.5.3. Egypt
14.5.3.1.
Egypt
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
14.5.3.1.1.
Hyaluronic
Dermal Fillers
14.5.3.1.1.1. Monophasic HA Fillers
14.5.3.1.1.2. Biphasic HA Fillers
14.5.3.1.2.
Polymethylmethacrylate
(PMMA)
14.5.3.1.3.
Collagen
14.5.3.1.4.
Poly-L-
Lactic Acid (PLLA)
14.5.3.1.5.
Calcium
Hydroxylapatite (CaHA)
14.5.3.1.6.
Polytetrafluoroethylene
14.5.3.1.7.
Autologous
Fat
14.5.3.2.
Egypt
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
14.5.3.2.1.
Wrinkles
14.5.3.2.2.
Lip
Enhancement
14.5.3.2.3.
Facial
Contouring
14.5.3.2.4.
Glabellar
Furrows
14.5.3.2.5.
Peri-Orbital
14.5.3.2.6.
Others
14.5.3.3.
Egypt
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.5.3.3.1.
Online
14.5.3.3.2.
Offline
14.5.3.3.2.1. Retail stores and Drug stores
14.5.3.3.2.2. Clinical pharmacies
14.5.3.3.2.3. Others
14.5.4. Kuwait
14.5.4.1.
Kuwait
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
14.5.4.1.1.
Hyaluronic
Dermal Fillers
14.5.4.1.1.1. Monophasic HA Fillers
14.5.4.1.1.2. Biphasic HA Fillers
14.5.4.1.2.
Polymethylmethacrylate
(PMMA)
14.5.4.1.3.
Collagen
14.5.4.1.4.
Poly-L-
Lactic Acid (PLLA)
14.5.4.1.5.
Calcium
Hydroxylapatite (CaHA)
14.5.4.1.6.
Polytetrafluoroethylene
14.5.4.1.7.
Autologous
Fat
14.5.4.2.
Kuwait
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
14.5.4.2.1.
Wrinkles
14.5.4.2.2.
Lip Enhancement
14.5.4.2.3.
Facial
Contouring
14.5.4.2.4.
Glabellar
Furrows
14.5.4.2.5.
Peri-Orbital
14.5.4.2.6.
Others
14.5.4.3.
Kuwait
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.5.4.3.1.
Online
14.5.4.3.2.
Offline
14.5.4.3.2.1. Retail stores and Drug stores
14.5.4.3.2.2. Clinical pharmacies
14.5.4.3.2.3. Others
14.5.5. South Africa
14.5.5.1.
South
Africa Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
14.5.5.1.1.
Hyaluronic
Dermal Fillers
14.5.5.1.1.1. Monophasic HA Fillers
14.5.5.1.1.2. Biphasic HA Fillers
14.5.5.1.2.
Polymethylmethacrylate
(PMMA)
14.5.5.1.3.
Collagen
14.5.5.1.4.
Poly-L-
Lactic Acid (PLLA)
14.5.5.1.5.
Calcium
Hydroxylapatite (CaHA)
14.5.5.1.6.
Polytetrafluoroethylene
14.5.5.1.7.
Autologous
Fat
14.5.5.2.
South
Africa Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
14.5.5.2.1.
Wrinkles
14.5.5.2.2.
Lip
Enhancement
14.5.5.2.3.
Facial
Contouring
14.5.5.2.4.
Glabellar
Furrows
14.5.5.2.5.
Peri-Orbital
14.5.5.2.6.
Others
14.5.5.3.
South
Africa Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.5.5.3.1.
Online
14.5.5.3.2.
Offline
14.5.5.3.2.1. Retail stores and Drug stores
14.5.5.3.2.2. Clinical pharmacies
14.5.5.3.2.3. Others
14.5.6. Rest of Middle East & Africa
14.5.6.1.
Rest of
Middle East & Africa Dermal Fillers Market Revenue (US$ Mn) and Forecasts,
By Type
14.5.6.1.1.
Hyaluronic
Dermal Fillers
14.5.6.1.1.1. Monophasic HA Fillers
14.5.6.1.1.2. Biphasic HA Fillers
14.5.6.1.2.
Polymethylmethacrylate
(PMMA)
14.5.6.1.3.
Collagen
14.5.6.1.4.
Poly-L-
Lactic Acid (PLLA)
14.5.6.1.5.
Calcium
Hydroxylapatite (CaHA)
14.5.6.1.6.
Polytetrafluoroethylene
14.5.6.1.7.
Autologous
Fat
14.5.6.2.
Rest of
Middle East & Africa Dermal Fillers Market Revenue (US$ Mn) and Forecasts,
By Application
14.5.6.2.1.
Wrinkles
14.5.6.2.2.
Lip
Enhancement
14.5.6.2.3.
Facial
Contouring
14.5.6.2.4.
Glabellar
Furrows
14.5.6.2.5.
Peri-Orbital
14.5.6.2.6.
Others
14.5.6.3.
Rest of
Middle East & Africa Dermal Fillers Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
14.5.6.3.1.
Online
14.5.6.3.2.
Offline
14.5.6.3.2.1. Retail stores and Drug stores
14.5.6.3.2.2. Clinical pharmacies
14.5.6.3.2.3. Others
14.6. Key Segment for Channeling Investments
14.6.1. By Country
14.6.2. By Type
14.6.3. By Application
14.6.4. By Distribution Channel
15. Latin America Dermal Fillers Market Analysis
and Forecasts, 2023 - 2031
15.1. Overview
15.1.1. Latin America Dermal Fillers Market Revenue
(US$ Mn)
15.2. Latin America Dermal Fillers Market Revenue
(US$ Mn) and Forecasts, By Type
15.2.1. Hyaluronic Dermal Fillers
15.2.1.1.
Monophasic
HA Fillers
15.2.1.2.
Biphasic
HA Fillers
15.2.2. Polymethylmethacrylate (PMMA)
15.2.3. Collagen
15.2.4. Poly-L- Lactic Acid (PLLA)
15.2.5. Calcium Hydroxylapatite (CaHA)
15.2.6. Polytetrafluoroethylene
15.2.7. Autologous Fat
15.3. Latin America Dermal Fillers Market Revenue
(US$ Mn) and Forecasts, By Application
15.3.1. Wrinkles
15.3.2. Lip Enhancement
15.3.3. Facial Contouring
15.3.4. Glabellar Furrows
15.3.5. Peri-Orbital
15.3.6. Others
15.4. Latin America Dermal Fillers Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
15.4.1. Online
15.4.2. Offline
15.4.2.1.
Retail
stores and Drug stores
15.4.2.2.
Clinical
pharmacies
15.4.2.3.
Others
15.5. Latin America Dermal Fillers Market Revenue
(US$ Mn) and Forecasts, By Country
15.5.1. Brazil
15.5.1.1.
Brazil
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
15.5.1.1.1.
Hyaluronic
Dermal Fillers
15.5.1.1.1.1. Monophasic HA Fillers
15.5.1.1.1.2. Biphasic HA Fillers
15.5.1.1.2.
Polymethylmethacrylate
(PMMA)
15.5.1.1.3.
Collagen
15.5.1.1.4.
Poly-L- Lactic
Acid (PLLA)
15.5.1.1.5.
Calcium
Hydroxylapatite (CaHA)
15.5.1.1.6.
Polytetrafluoroethylene
15.5.1.1.7.
Autologous
Fat
15.5.1.2.
Brazil
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
15.5.1.2.1.
Wrinkles
15.5.1.2.2.
Lip
Enhancement
15.5.1.2.3.
Facial
Contouring
15.5.1.2.4.
Glabellar
Furrows
15.5.1.2.5.
Peri-Orbital
15.5.1.2.6.
Others
15.5.1.3.
Brazil
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
15.5.1.3.1.
Online
15.5.1.3.2.
Offline
15.5.1.3.2.1. Retail stores and Drug stores
15.5.1.3.2.2. Clinical pharmacies
15.5.1.3.2.3. Others
15.5.2. Argentina
15.5.2.1.
Argentina
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
15.5.2.1.1.
Hyaluronic
Dermal Fillers
15.5.2.1.1.1. Monophasic HA Fillers
15.5.2.1.1.2. Biphasic HA Fillers
15.5.2.1.2.
Polymethylmethacrylate
(PMMA)
15.5.2.1.3.
Collagen
15.5.2.1.4.
Poly-L-
Lactic Acid (PLLA)
15.5.2.1.5.
Calcium
Hydroxylapatite (CaHA)
15.5.2.1.6.
Polytetrafluoroethylene
15.5.2.1.7.
Autologous
Fat
15.5.2.2.
Argentina
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Application
15.5.2.2.1.
Wrinkles
15.5.2.2.2.
Lip
Enhancement
15.5.2.2.3.
Facial
Contouring
15.5.2.2.4.
Glabellar
Furrows
15.5.2.2.5.
Peri-Orbital
15.5.2.2.6.
Others
15.5.2.3.
Argentina
Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
15.5.2.3.1.
Online
15.5.2.3.2.
Offline
15.5.2.3.2.1. Retail stores and Drug stores
15.5.2.3.2.2. Clinical pharmacies
15.5.2.3.2.3. Others
15.5.3. Rest of Latin America
15.5.3.1.
Rest of
Latin America Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By Type
15.5.3.1.1.
Hyaluronic
Dermal Fillers
15.5.3.1.1.1. Monophasic HA Fillers
15.5.3.1.1.2. Biphasic HA Fillers
15.5.3.1.2.
Polymethylmethacrylate
(PMMA)
15.5.3.1.3.
Collagen
15.5.3.1.4.
Poly-L-
Lactic Acid (PLLA)
15.5.3.1.5.
Calcium
Hydroxylapatite (CaHA)
15.5.3.1.6.
Polytetrafluoroethylene
15.5.3.1.7.
Autologous
Fat
15.5.3.2.
Rest of
Latin America Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By
Application
15.5.3.2.1.
Wrinkles
15.5.3.2.2.
Lip
Enhancement
15.5.3.2.3.
Facial
Contouring
15.5.3.2.4.
Glabellar
Furrows
15.5.3.2.5.
Peri-Orbital
15.5.3.2.6.
Others
15.5.3.3.
Rest of
Latin America Dermal Fillers Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.5.3.3.1.
Online
15.5.3.3.2.
Offline
15.5.3.3.2.1. Retail stores and Drug stores
15.5.3.3.2.2. Clinical pharmacies
15.5.3.3.2.3. Others
15.6. Key Segment for Channeling Investments
15.6.1. By Country
15.6.2. By Type
15.6.3. By Application
15.6.4. By Distribution Channel
16. Competitive Benchmarking
16.1. Brand Benchmarking
16.2. Market Share Analysis, 2022
16.3. Global Presence and Growth Strategies
16.3.1. Mergers and Acquisitions
16.3.2. Product Launches
16.3.3. Investments Trends
16.3.4. R&D Initiatives
17. Player Profiles
17.1. Allergan Plc (AbbVie)
17.1.1. Company Details
17.1.2. Company Overview
17.1.3. Product Offerings
17.1.4. Key Developments
17.1.5. Financial Analysis
17.1.6. SWOT Analysis
17.1.7. Business Strategies
17.2. BioPlus Co., Ltd
17.2.1. Company Details
17.2.2. Company Overview
17.2.3. Product Offerings
17.2.4. Key Developments
17.2.5. Financial Analysis
17.2.6. SWOT Analysis
17.2.7. Business Strategies
17.3. Bohus BioTech AB
17.3.1. Company Details
17.3.2. Company Overview
17.3.3. Product Offerings
17.3.4. Key Developments
17.3.5. Financial Analysis
17.3.6. SWOT Analysis
17.3.7. Business Strategies
17.4. Fidia Farmaceutici S.p.A.
17.4.1. Company Details
17.4.2. Company Overview
17.4.3. Product Offerings
17.4.4. Key Developments
17.4.5. Financial Analysis
17.4.6. SWOT Analysis
17.4.7. Business Strategies
17.5. Galderma
17.5.1. Company Details
17.5.2. Company Overview
17.5.3. Product Offerings
17.5.4. Key Developments
17.5.5. Financial Analysis
17.5.6. SWOT Analysis
17.5.7. Business Strategies
17.6. LG Lifescienecs
17.6.1. Company Details
17.6.2. Company Overview
17.6.3. Product Offerings
17.6.4. Key Developments
17.6.5. Financial Analysis
17.6.6. SWOT Analysis
17.6.7. Business Strategies
17.7. Luminera Derm Ltd
17.7.1. Company Details
17.7.2. Company Overview
17.7.3. Product Offerings
17.7.4. Key Developments
17.7.5. Financial Analysis
17.7.6. SWOT Analysis
17.7.7. Business Strategies
17.8. Matex Lab SA (Neauvia)
17.8.1. Company Details
17.8.2. Company Overview
17.8.3. Product Offerings
17.8.4. Key Developments
17.8.5. Financial Analysis
17.8.6. SWOT Analysis
17.8.7. Business Strategies
17.9. Merz Pharma
17.9.1. Company Details
17.9.2. Company Overview
17.9.3. Product Offerings
17.9.4. Key Developments
17.9.5. Financial Analysis
17.9.6. SWOT Analysis
17.9.7. Business Strategies
17.10. Prollenium Medical Technologies
17.10.1. Company Details
17.10.2. Company Overview
17.10.3. Product Offerings
17.10.4. Key Developments
17.10.5. Financial Analysis
17.10.6. SWOT Analysis
17.10.7. Business Strategies
17.11. SciVision Biotech Inc.
17.11.1. Company Details
17.11.2. Company Overview
17.11.3. Product Offerings
17.11.4. Key Developments
17.11.5. Financial Analysis
17.11.6. SWOT Analysis
17.11.7. Business Strategies
17.12. Sinclair Pharma
17.12.1. Company Details
17.12.2. Company Overview
17.12.3. Product Offerings
17.12.4. Key Developments
17.12.5. Financial Analysis
17.12.6. SWOT Analysis
17.12.7. Business Strategies
17.13. Suneva Medical, Inc.
17.13.1. Company Details
17.13.2. Company Overview
17.13.3. Product Offerings
17.13.4. Key Developments
17.13.5. Financial Analysis
17.13.6. SWOT Analysis
17.13.7. Business Strategies
17.14. Teoxane
17.14.1. Company Details
17.14.2. Company Overview
17.14.3. Product Offerings
17.14.4. Key Developments
17.14.5. Financial Analysis
17.14.6. SWOT Analysis
17.14.7. Business Strategies
17.15. Zimmer Aesthetics
17.15.1. Company Details
17.15.2. Company Overview
17.15.3. Product Offerings
17.15.4. Key Developments
17.15.5. Financial Analysis
17.15.6. SWOT Analysis
17.15.7. Business Strategies
17.16. Other Market Participants
18. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.